MedTrace Logo

Mulligan and Proprioceptive Neuromuscular Fasciliation Techiniques in Rotator Cuff Pathology

NCT06213584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-01-19

No results posted yet for this study

Summary

The aim of this study is to investigate the effects of Mulligan Mobilization techniques, Mobilization with Movement (MWMs) and Proprioceptive Neuromuscular Facilitation (PNF) techniques, Hold-Relax Active Movement Technique, on pain, normal joint range of motion, proprioception, scapular dyskinesia and functional status in individuals with rotator cuff syndrome.

A total of 60 people were included in the study: 20 participants in the censervative rehabilitation group (Conservative Treatment), 20 participants in the Treatment A (Mulligan Mobilization Application) Group, and 20 participants in the Treatment B (PNF Application) Group. Individuals were treated for 5 days for 4 weeks. Pain before and after treatment with Visual Analog Scale; joint range of motion with goniometer; With proprioception Angle Repetition Test; Scapular dyskinesia with Lateral Scapular Slide Test; quality of life with SF-36; shoulder functionality was assessed with the Western Ontario Rotator Cuff Scale (WORC).

Conditions

  • Rotator Cuff Injuries

Interventions

OTHER

conservative rehabilitation

Hotpack + TENS + streching exercises

OTHER

mullgan mobilization techniques

Passive mobilization techniques during active movements

OTHER

pnf

hold relax active movements

Sponsors & Collaborators

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Gamze AYDIN · Okan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-05
Primary Completion
2021-03-05
Completion
2022-03-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06213584 on ClinicalTrials.gov